Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inactivated Convalescent Plasma as a Therapeutic Alternative in Hospitalized Patients CoViD-19

NCT04385186 is registered in ClinicalTrials.gov with National Blood Center Foundation, Hemolife as lead sponsor.

NCT NCT04385186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inactivated Convalescent Plasma as a Therapeutic Alternative in Hospitalized Patients CoViD-19
Lead sponsor
National Blood Center Foundation, Hemolife
Phase
Phase 2
Overall status
Unknown status
Start date
June 20, 2020
Completion date
December 30, 2020
Enrollment
60 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

infections, coronavirus